HCW Biologics Inc. (NASDAQ:HCWB – Get Rating) Director Rick S. Greene bought 4,800 shares of the stock in a transaction that occurred on Thursday, June 2nd. The shares were purchased at an average price of $2.09 per share, for a total transaction of $10,032.00. Following the purchase, the director now owns 8,411 shares in the […]
HCW Biologics Inc. (NASDAQ:HCWB – Get Rating) saw a significant decrease in short interest in April. As of April 30th, there was short interest totalling 30,100 shares, a decrease of 32.5% from the April 15th total of 44,600 shares. Based on an average daily volume of 32,700 shares, the days-to-cover ratio is presently 0.9 days. […]